SCHEMBL13426257

SCHEMBL13426257

c1ccc2c(c1)CCc1ccccc1N2c1c2ccc(N3CCCCC3)cc2c(-c2cccc3ccccc23)c2ccc(N3CCCCC3)cc12

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AVPR2 P30518 3/20 0.36
TERT O14746 1/20 0.34
MEN1 O00255 4/20 0.34
KMT2A Q03164 4/20 0.34
MAPT P10636 3/20 0.34
L3MBTL1 Q9Y468 3/20 0.34
HTT P42858 2/20 0.34
TLR9 Q9NR96 2/20 0.34
ALDH1A1 P00352 4/20 0.34
HSD17B10 Q99714 2/20 0.34
KDM4E B2RXH2 2/20 0.34
NPC1 O15118 1/20 0.34
HPGD P15428 1/20 0.34
RAB9A P51151 1/20 0.34
PRKDC P78527 2/20 0.33
SLC6A2 P23975 1/20 0.32
SLC6A4 P31645 1/20 0.32
SLC6A3 Q01959 1/20 0.32
USP2 O75604 2/20 0.32
LMNA P02545 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13426205 0.94 TERT (0.34) AVPR2TERTMEN1KMT2AMAPT
SCHEMBL13426228 0.86 PRKDC (0.35) TERTMEN1KMT2AMAPTL3MBTL1
SCHEMBL13425860 0.85 AVPR2 (0.45) AVPR2TERTMEN1KMT2AMAPT
SCHEMBL13425563 0.85 ALDH1A1 (0.42) TERTMEN1KMT2AMAPTL3MBTL1
SCHEMBL13009166 0.84 POLB (0.38) MAPTHTTALDH1A1HSD17B10KDM4E
SCHEMBL13425984 0.83 AVPR2 (0.39) AVPR2TERTMEN1KMT2AMAPT
SCHEMBL13426096 0.83 HTR3A (0.38) AVPR2TERTMEN1KMT2AMAPT
SCHEMBL13426201 0.82 SLC6A2 (0.35) AVPR2MAPTALDH1A1NPC1HPGD
SCHEMBL13426123 0.81 KDM4E (0.40) TERTMEN1KMT2AMAPTHTT
SCHEMBL13009190 0.81 POLB (0.35) HTTALDH1A1KDM4EHPGDLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100051106-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-03-04 US disclosed
US-20100051106-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-03-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100051106-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same RPL36, RPL39, RPL36A AVPR2 2997/4885TERT 323/4885MEN1 3994/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.